Birchtech Corp. Reports Revenue Growth to $7.36 Million in Q3 2025

Birchtech Corp. reported a significant increase in revenue for the third quarter of 2025, generating approximately $7.36 million, compared to $5.24 million in the same period last year. This growth was primarily driven by a substantial rise in licensing revenue, which surged to $2.6 million from just $133,000 in the prior year. For the nine months ending September 30, 2025, total revenues reached approximately $13.84 million, up from $11.84 million in 2024. The company attributed this increase to new licensing agreements and a shift in product sales dynamics, despite a decline in product revenue from $11.48 million to $10.64 million over the same period.

The company's financial performance showed a marked improvement in profitability, with a net income of $788,000 for the third quarter of 2025, compared to a net loss of $458,000 in the same quarter of 2024. For the nine-month period, the net loss narrowed to approximately $2.43 million from $9.46 million in the previous year. This improvement was largely due to higher licensing revenues, which typically carry better margins than product sales, and a reduction in operating expenses, particularly in selling, general, and administrative costs.

In terms of operational developments, Birchtech has made strategic moves to expand its market presence, particularly in the water treatment sector. The company opened two state-of-the-art laboratories in Pennsylvania and North Dakota, aimed at developing new sorbent technologies for water purification, specifically targeting harmful "forever chemicals" like PFAS. This initiative is expected to create a new revenue stream and enhance the company's competitive position in the growing water treatment market. Additionally, the company has appointed key personnel to lead this new business line, including David Mazyck as Executive Director of Innovation and Commercialization.

Despite these advancements, Birchtech faces challenges, including a working capital deficiency of approximately $5 million as of September 30, 2025, and an accumulated deficit of $75.19 million. The company reported cash and cash equivalents of $1.77 million, down from $3.46 million at the end of 2024. Management has expressed concerns about the company's ability to continue as a going concern within the next year, citing the need for additional cash inflows from ongoing litigation and new product sales to stabilize its financial position.

Looking ahead, Birchtech is optimistic about its future, with plans to leverage the recent $57.1 million jury verdict in its favor from patent litigation to bolster its financial standing. The company is also exploring additional financing opportunities to support its operations and growth initiatives. While management believes these strategies will help mitigate current financial challenges, they acknowledge the inherent uncertainties and risks associated with their execution.